Home / General / US FDA Authorizes Early Access to Revolution’s Pancreatic Cancer Pill

US FDA Authorizes Early Access to Revolution’s Pancreatic Cancer Pill

US News is a recognized leader in college, grad school, hospital, mutual fund, and car rankings. Track elected officials, research health conditions, and find news you can use in politics, business, health, and education.

May 1 (Reuters) – The U.S. Food ⁠and ⁠Drug Administration has authorized ⁠the granting of early access before ​regulatory approval to Revolution Medicines’ pill for patients with previously ‌treated pancreatic cancer, the ‌company said on Friday.
The… [1297 chars]

Source: U.S. News & World Report | Published: 2026-05-01T16:54:00Z

Credit: U.S. News & World Report

Tagged: